Royal Bank of Canada
CINC

Royal Bank of Canada’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Royal Bank of Canada’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,906
Closed -$35K – 7791
2022
Q4 		$35K Buy
2,906
+2,662
+1,091% +$63.4K ﹤0.01% 6082
2022
Q3 		$8K Buy
244
+169
+225% +$4.78K ﹤0.01% 6568
2022
Q2 		$1K Sell
75
-938
-93% -$18K ﹤0.01% 7283
2022
Q1 		$18K Buy
+1,013
New +$20.8K ﹤0.01% 6678

Royal Bank of Canada's CINC Position: Q1 2023 in Review

Royal Bank of Canada sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 2,906 shares — an estimated $35K sold.

Royal Bank of Canada first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $35K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Royal Bank of Canada reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 2,906 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $35K.
  • Royal Bank of Canada first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Royal Bank of Canada's CinCor Pharma, Inc. Common Stock position peaked at $35K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.